Structure-Activity Relationships in Toll-Like Receptor 2-Agonists Leading to Simplified Monoacyl Lipopeptides

被引:53
作者
Agnihotri, Geetanjali [1 ]
Crall, Breanna M. [1 ]
Lewis, Tyler C. [1 ]
Day, Timothy P. [1 ]
Balakrishna, Rajalakshmi [1 ]
Warshakoon, Hemamali J. [1 ]
Malladi, Subbalakshmi S. [1 ]
David, Sunil A. [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66047 USA
关键词
MONOPHOSPHORYL-LIPID-A; T-CELL POLARIZATION; VACCINE ADJUVANT; RESPONSES; TLR2; TH2; LIPOPOLYSACCHARIDE; SEQUESTRANTS; ACTIVATION; SECRETION;
D O I
10.1021/jm201071e
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Toll-like receptor 2-agonistic lipopeptides typified by S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-R-cystein-yl-S-serine (PAM(2)CS) compounds are potential vaccine adjuvants. In continuation of previously reported structure activity relationships on this chemotype, we have determined that at least one acyl group of optimal length (C-16) and an appropriately oriented ester carbonyl group is essential for TLR2-agonistic activity. The spacing between one of the palmitoyl ester carbonyl and the thioether is crucial to allow for an important H-bond, which observed in the crystal structure of the lipopeptide:TLR2 complex; consequently, activity is lost in homologated compounds. Penicillamine-derived analogues are also inactive, likely due to unfavorable steric interactions with the carbonyl of Ser 12 in TLR2. The thioether in this chemotype can be replaced with a selenoether. Importantly, the thioglycerol motif can be dispensed with altogether and can be replaced with a thioethanol bridge. These results have led to a structurally simpler, synthetically more accessible, and water-soluble analogue possessing strong TLR2-agonistic activities in human blood,
引用
收藏
页码:8148 / 8160
页数:13
相关论文
共 41 条
  • [1] TLR2-activated human langerhans cells promote Th17 polarization via IL-1β, TGF-β and IL-23
    Aliahmadi, Ehsan
    Gramlich, Robert
    Gruetzkau, Andreas
    Hitzler, Manuel
    Krueger, Melanie
    Baumgrass, Ria
    Schreiner, Maximilian
    Wittig, Burghardt
    Wanner, Reinhard
    Peiser, Matthias
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (05) : 1221 - 1230
  • [2] Toll-like receptor signaling mechanisms involved in dendritic cell activation:: Potential therapeutic control of T cell polarization
    Amati, Luigi
    Pepe, Maria
    Passeri, Maria Elena
    Mastronardi, Maria Letizia
    Jirillo, Emilio
    Covelli, Vito
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (32) : 4247 - 4254
  • [3] Lipopeptide structure determines TLR2 dependent cell activation level
    Buwitt-Beckmann, U
    Heine, H
    Wiesmüller, KH
    Jung, G
    Brock, R
    Ulmer, AJ
    [J]. FEBS JOURNAL, 2005, 272 (24) : 6354 - 6364
  • [4] Toll-like receptor 6-independent signaling by diacylated lipopeptides
    Buwitt-Beckmann, U
    Heine, H
    Wiesmüller, KH
    Jung, G
    Brock, R
    Akira, S
    Ulmer, AJ
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (01) : 282 - 289
  • [5] Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant
    Casella, C. R.
    Mitchell, T. C.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (20) : 3231 - 3240
  • [6] COFFMAN RL, 1988, MONOGR ALLERGY, V24, P96
  • [7] Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
    Coler, Rhea N.
    Bertholet, Sylvie
    Moutaftsi, Magdalini
    Guderian, Jeff A.
    Windish, Hillarie Plessner
    Baldwin, Susan L.
    Laughlin, Elsa M.
    Duthie, Malcolm S.
    Fox, Christopher B.
    Carter, Darrick
    Friede, Martin
    Vedvick, Thomas S.
    Reed, Steven G.
    [J]. PLOS ONE, 2011, 6 (01):
  • [8] A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines
    Coler, Rhea N.
    Baldwin, Susan L.
    Shaverdian, Narek
    Bertholet, Sylvie
    Reed, Steven J.
    Raman, Vanitha S.
    Lu, Xiuhua
    DeVos, Joshua
    Hancock, Kathy
    Katz, Jacqueline M.
    Vedvick, Thomas S.
    Duthie, Malcolm S.
    Clegg, Christopher H.
    Van Hoeven, Neal
    Reed, Steven G.
    [J]. PLOS ONE, 2010, 5 (10):
  • [9] Toll-like receptors and T-helper-1/T-helper-2 responses
    Dabbagh, K
    Lewis, DB
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2003, 16 (03) : 199 - 204
  • [10] El Sahly H, 2010, EXPERT REV VACCINES, V9, P1135, DOI [10.1586/ERV.10.111, 10.1586/erv.10.111]